A service evaluation of the Gen-Probe APTIMA nucleic acid amplification test forTrichomonas vaginalis: should it change whom we screen for infection?
- 28 August 2014
- journal article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 91 (2) , 81-86
Abstract
Objective A service evaluation of the new Gen-Probe APTIMA nucleic acid amplification test was performed to determine the prevalence of Trichomonas vaginalis (TV) infection in a UK sexual health clinic and identify risk factors to inform an appropriate TV screening strategy. Method Unselected patients presenting with a new clinical episode were offered TV testing with Gen Probe transcription-mediated amplification (TV TMA) in addition to routine sexually transmitted infection screening. Asymptomatic females provided a self-collected vulvovaginal specimen and asymptomatic men a first-void urine sample. Symptomatic patients were examined and a urethral swab taken from men and two posterior vaginal swabs from females; one for culture and one for TV TMA testing. Demographic and clinical data were collected on all patients positive for TV infection and 100 randomly selected TV-negative controls. Results 3503 patients underwent TV TMA testing during the evaluation period. The prevalence of TV infection was 21/1483, 1.4% (95% CI 0.9% to 2.2%) in men and 72/2020, 3.6% (95% CI 2.8% to 4.5%) in women. The rate of TV positivity was higher in Black Caribbean patients compared with Caucasian patients (men 5.4% vs 0.1%, pConclusions While screening all patients with TV TMA will identify more TV infections, the UK prevalence remains low and this approach is unlikely to be cost effective. In addition to testing symptomatic patients, targeted testing of high-risk asymptomatic groups using TV TMA should be considered.Keywords
This publication has 28 references indexed in Scilit:
- Trichomoniasis and HIV interactions: a reviewSexually Transmitted Infections, 2013
- Trichomonas vaginalisinfection in men who submit self-collected penile swabs after internet recruitmentSexually Transmitted Infections, 2013
- Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification AssayJournal of Clinical Microbiology, 2012
- Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, in pouch TV culture system, and PCRJournal of Global Infectious Diseases, 2012
- Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinicsSexually Transmitted Infections, 2009
- Comparison between the Gen-Probe Transcription-Mediated Amplification Trichomonas vaginalis Research Assay and Real-Time PCR for Trichomonas vaginalis Detection Using a Roche LightCycler Instrument with Female Self-Obtained Vaginal Swab Samples and Male Urine SamplesJournal of Clinical Microbiology, 2006
- Methods for Detection of Trichomonas vaginalis in the Male Partners of Infected Women: Implications for Control of TrichomoniasisJournal of Clinical Microbiology, 2006
- Trichomonas vaginalis Is Associated with Pelvic Inflammatory Disease in Women Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2002
- Trichomonas vaginalis Associated With Low Birth Weight and Preterm DeliverySexually Transmitted Diseases, 1997
- Comparison of Direct Fluorescent Antibody, Acridine Orange, Wet Mount, and Culture for Detection of Trichomonas vaginalis in Women Attending a Public Sexually Transmitted Diseases ClinicSexually Transmitted Diseases, 1989